Glenmark Pharma: Latest News and Updates, Top Stories, Videos, Photos About Glenmark Pharma

Nirma To Acquire Stake In Glenmark Life Sciences: Check Number Of Shares On Sale, Transaction Details Here

Shares of Glenmark Life Sciences grabbed investors' attention on Friday (September 22) after an exchange filing revealed that Nirma Limited has entered into a share purchase agreement dated September 21, 2023, with the Seller and the Target Company (Glenmark Life Sciences ...

BOB Capital Has Given 'Buy' Rating to This Pharma Stock For Up To 44% Potential Gains

BOB Capital Markets has been bullish on Glenmark Life Sciences Ltd and suggests buying for a target price of Rs 620/share. Glenmark Life Sciences is a pioneer in the development and manufacture of high-value, non-commoditized Active Pharmaceutical Ingredients (APIs) for chronic ...

Glenmark Pharma Climbs After Exclusive Licensing Agreement With Menarini

On Wednesday, shares of Glenmark Pharmaceuticals Ltd rose as much as 2% to Rs 497.70 after the Mumbai-based company announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its ...

Glenmark Pharma Included In Dow Jones Sustainability Index For The Third Year In A Row

For the third consecutive year in a row, Glenmark Pharmaceuticals Ltd announced that it has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets. DJSI is one of the world's most respected and widely accepted ...

Glenmark Pharma Jumps 7% On Doubling Q1 Net Profit

On Monday, shares of Glenmark Pharma gained as much as 7 percent to Rs 509 after the company reported an over two-fold increase in consolidated net profit at Rs 254.04 crore for the June-ended quarter. For the same period last year, ...

Glenmark Pharma Slips Over 5% After DCGI Issues Notices

On Monday, shares of Glenmark Pharmaceuticals Ltd fell over by 5 percent to an intraday low of Rs 405 after the Drug Controller General of India (DCGI) issued notices to the company seeking clarification over its alleged "false claims" about the ...

Glenmark Pharma Shares Jump 40% On Launch Of New COVID-19 Drug

Shares of Glenmark Pharmaceuticals rose as much as 40 percent, its biggest-ever intraday gain, to its 52-week high of Rs 573.05 on Monday on launching its antiviral drug Favipiravir for the treatment of COVID-19 patients with mild to moderate symptoms. ...

Glenmark Pharma To Study Potential COVID-19 Drug Combo; Shares Gain 5th Straight Day

Shares of Glenmark Pharma rose as much as 2.4 percent to Rs 360.5 apiece for the fifth straight day on Tuesday after the drugmaker informed the exchanges that it will be commencing a new phase of 3 clinical trials on hospitalised ...

Glenmark Pharma Shares Spike 9% On CLSA’s Rating Upgrade

On Monday, shares of Glenmark Pharmaceuticals extended its gains for the third consecutive session, gaining close to 9 percent to Rs 328.50 apiece on NSE. The surge comes after brokerage and research firm CLSA upgraded its rating on the stock from ...

Glenmark Pharma Stock Hits 6-Year Low After USFDA Issues CRL

Shares of Glenmark Pharmaceuticals fell close to 7 percent to Rs 466.25 apiece, its lowest since 4 April 2013, in early trade on Monday. According to the company's stock exchange filing, the US FDA (Food and Drug Administration of the United ...

These Pharma Stocks Rise After Receiving FDA Approval

Shares of Sun Pharmaceutical Industries was trading 1.6 percent higher at Rs 460.15 on NSE (National Stock Exchange) after it received approval from US health regulator FDA (Food and Drug Administration) for a cancer drug Yonsa from one of its subsidiaries. ...

Stocks Brokerages Are Recommending Investors To Buy

Markets have begun the year on a buoyant note. Here are select stocks that brokerages are recommending investors to buy.{photo-feature}...

Glenmark Pharma News